6–$32M incl 11M non-cash impairments (vs net income 78M Y/Y); adj diluted EPS $0.47–$0.53 (vs $0.84 Y/Y); Europe parts organic -9.8%, segment EBITDA margin 4.1–5.1% (vs 10.0%) on Germany ERP disruption; FY26 guidance WITHDRAWN; CEO Justin Jude departed Oct 23, Salvatore A. Abbate named successor effective Dec 15 (interim Office of CEO: Chairman John Mendel + Audit Chair Sue Gove); Andy Hamilton out as President of LKQ Europe; Alvarez & Marsal retained to advise European ops; stock -22.47% to 7.42 on 23.4M vol (vs 3.7M avg); Barrington Research downgrade to Market Perform" /> 6–$32M incl 11M non-cash impairments (vs net income 78M Y/Y); adj diluted EPS $0.47–$0.53 (vs $0.84 Y/Y); Europe parts organic -9.8%, segment EBITDA margin 4.1–5.1% (vs 10.0%) on Germany ERP disruption; FY26 guidance WITHDRAWN; CEO Justin Jude departed Oct 23, Salvatore A. Abbate named successor effective Dec 15 (interim Office of CEO: Chairman John Mendel + Audit Chair Sue Gove); Andy Hamilton out as President of LKQ Europe; Alvarez & Marsal retained to advise European ops; stock -22.47% to 7.42 on 23.4M vol (vs 3.7M avg); Barrington Research downgrade to Market Perform" />